R&D Archives | Be Korea-savvy
S. Korea to Set up 113.5 Bln-Won Fund to Help Bio Startups

S. Korea to Set up 113.5 Bln-Won Fund to Help Bio Startups

SEOUL, March 27 (Korea Bizwire) – South Korea will establish a 113.5 billion-won (US$101.8 million) fund to nurture startups and venture firms in the bio sector to secure new growth engines, the science ministry said Monday. Under the comprehensive plan finalized during a government meeting presided over by Acting President and Prime Minister Hwang Kyo-ahn, [...]

Major Pharmaceuticals to Expand R&D Spending in 2017

Major Pharmaceuticals to Expand R&D Spending in 2017

SEOUL, March 21 (Korea Bizwire) – Major South Korean pharmaceutical companies are poised to expand their spending on research and development (R&D) this year despite weak earnings, industry sources said Tuesday.  The four drug companies — Hanmi Pharmaceutical Co., Green Cross Corp., Daewoong Pharma and Chong Kun Dang Pharmaceutical Corp. — whose annual R&D spending [...]

Less Than 1 in 5 Medical Device Companies to Increase R&D Positions: Survey

Less Than 1 in 5 Medical Device Companies to Increase R&D Positions: Survey

SEOUL, Feb. 20 (Korea Bizwire) – Less than one in five South Korean manufacturers of medical supplies and equipment said they plan to increase new research and development (R&D) jobs, a survey showed Monday, despite the government’s push to become a global biotech and medical industry hub.  According to the survey by the Korea Medical [...]

Annual R&D Spending Tops 100 Bln Won at 4 Korean Drug Firms

Annual R&D Spending Tops 100 Bln Won at 4 Korean Drug Firms

SEOUL, Feb. 14 (Korea Bizwire) – Four major South Korean pharmaceutical companies spent more than 100 billion won (US$86.9 million) each on research and development (R&D) in 2016, industry officials said Tuesday.  The four drug companies — Hanmi Pharmaceutical Co., Green Cross Corp., Daewoong Pharma and Chong Kun Dang Pharmaceutical Corp. — sharply expanded their [...]

Local Pharmaceutical Companies Fall Behind Foreign Rivals

Local Pharmaceutical Companies Fall Behind Foreign Rivals

SEOUL, Jan. 9 (Korea Bizwire) – Only one South Korean pharmaceutical company had a new drug approved in 2016, compared to 11 drugs introduced by overseas companies including Novartis, Gilead Sciences, and Pfizer. Olita Tablet, a lung cancer drug from Hanmi Pharmaceutical, was the only new drug introduced last year by a local company, and [...]

Samsung Electronics Retains No. 2 Spot in Global Research Spending

Samsung Electronics Retains No. 2 Spot in Global Research Spending

SEOUL, Dec. 27 (Korea Bizwire) – Samsung Electronics Co. retained its No. 2 spot in a global ranking for industrial research and development spending for the third consecutive year, a survey by the European Commission’s Economics of Industrial Research and Innovation showed Tuesday.  According to the annual survey, 75 South Korean firms were among the [...]

Companies Shifting More R&D Spending Away from Physical Products to Software and Services: 2016 Global Innovation 1000 Study

Companies Shifting More R&D Spending Away from Physical Products to Software and Services: 2016 Global Innovation 1000 Study

LONDON, Oct. 24 (Korea Bizwire) — By 2020, companies will have shifted the majority of their R&D spending away from product-based offerings to software and service offerings, according to the 2016 Global Innovation 1000 Study from Strategy&, PwC’s strategy consulting business. The need to stay competitive is the top reason why companies cited a shift [...]